Diligence memo · auto-generated · as of July 2, 2026
Exo Imaging, Inc.
Exo Imaging, Inc. looks fair against its niche peers and is active on financing cadence.
Businessfiled
Exo Imaging, Inc. operates in Other Health Care, based in SANTA CLARA.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Exo Imaging, Inc. has raised $170M in disclosed capital across 8 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $51M on 2020-04-22.
Most recent recorded round closed around 2025-05-28.
Valuation (modeled)modeled
Provath models Exo Imaging, Inc. at approximately $285M (range $160M–$382M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.26× the median modeled value of Series C Other Health Care companies in 2025–2027 (20 peers) — value vs value, same stage and era. Within the normal band (126% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 8 months.
Last raise 13 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
The last round stepped up 219.7× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 98% of Other Health Care peers (5377 compared).
Modeled value ranks above 90% of those peers.
Closest niche peers: RESTOR3D, Inc., ByHeart, Inc., SpyGlassPharma, Inc., VantAI Holdings, Inc., BioIntelliSense, Inc..
Peoplefiled
18 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.